Related Experiment Video
Updated: Oct 1, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
The application of genetics to the discovery of better medicines
1Oxagen Ltd, Abingdon, OX1 4RY, UK. r.pettipher@oxagen.co.uk
Abstract:
The availability of the human genome sequence and the increasing knowledge of functional polymorphisms will highlight new therapeutic approaches to treat diseases with unmet medical need and will allow the targeting of new and existing therapies to those patients who will derive the most benefit without the risk of serious side effects. This review describes how genetic information can be used to improve the drug discovery and development process. It should be emphasized, however, that although it is anticipated that high-throughput genetic studies will provide novel biological insights into disease, it is not a replacement for careful hypothesis-driven experiments. Rather, it is essential to combine genetic studies with carefully conducted preclinical and clinical experiments to extract the true value of high-throughput genetics-based research.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Principles of Pharmacogenetics: Types of Genetic Variants
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
